Latest Industry Insights
Industry Insight
Flagship Facility Supports Advanced Analytical Science
We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.
Industry Insight
Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies
Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.
Industry Insight
Failing Faster To Succeed Sooner in Drug Discovery
Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.
Industry Insight
Data-Driven Adaptive Trials: Enhancing Safety, Accelerating Progress and Boosting Economics Through Enhanced Insights
Trial sponsors are faced with vast amounts of diverse data and corresponding endpoints spanning all trial sites linked to their study design. This article explores how interactive response technology can help sponsors overcome these challenges.
Industry Insight
Accelerating and Refining With Mass Spectrometry
At ASMS 2023, Technology Networks spoke with Dr. Chris Lock, vice president of global research and development at SCIEX, to discuss the newly launched Intabio ZT system.
Industry Insight
Increasing Throughput While Protecting Proteome Coverage
At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.
Industry Insight
Investigating the Long-Term Safety of ADHD Medication for Children and Adolescents
Technology Networks spoke with Dr. Sarah Inglis, trial manager of a recent study investigating the safety of a common ADHD medication, methylphenidate, in children and adolescents.
Industry Insight
Applying AI Across All Stages of Drug Development
To learn more about the application of AI across all stages of development, from drug design to clinical trials, Technology Networks spoke with Dr. Yuan Wang, head of research analytics at UCB.
Industry Insight
The Rise of Weight Management Drug Wegovy
Technology Networks spoke with Novo Nordisk’s Clinical, Medical and Regulatory Affairs team to learn more about Wegovy, its popular weight management drug.
Industry Insight
Small Molecule KRAS Inhibitors With Potent Antitumor Activity
In this interview, Technology Networks spoke to Dr. Cameron Pitt to learn more about KRAS as a target for cancer therapeutics, avoiding known resistance mechanisms and the effectiveness of two novel KRAS inhibitors.
Advertisement
